ABSTRACT: Proper control of protein synthesis is vital for tissue homeostasis and its deregulation is characteristic of many disorders including osteoarthritis (OA). The objectives of this work were to analyze and correlate changes in activity of the translation apparatus associated with cartilage degeneration in an animal model of OA. Osteoarthritis was induced surgically in rats by anterior cruciate ligament transection (ACLT). Using a modified Mankin scoring system and analysis of protein expression we demonstrated, that mechanistic target of rapamycin complex 1 (mTORC1)-mediated 4E-BP1 phosphorylation was detected significantly earlier than other mTORC1-mediated modifications, such as p70S6K and ULK1 phosphorylation. 4E-BP1 is an inhibitor of cap-dependent translation those functions are inhibited by mTORC1 mediated phosphorylation. This signaling event not only preceded prominent signs of cartilage degeneration but also the increase in global protein synthesis rate. These results suggest that abnormal mTORC1 activity is one of the primary dysregulations observed in OA cartilage. Importantly, it is distributed disproportionately between targets, with 4E-BP1 being phosphorylated earlier than other downstream targets. Thus, our work provides new insights into the sequence of molecular events leading to cartilage destruction in OA and identifies translational control as an important regulatory hub involved in initiating OA. ß
Osteoarthritis (OA) is the most prevalent degenerative joint disease. It is characterized by progressive articular cartilage destruction, caused by a shift in the balance between anabolic and catabolic processes. 1 While cartilage degeneration is a hallmark of the disease, the complex nature of OA indicates that it is not simply a "cartilage" disease, but a pathology involving the whole joint. 2, 3 Despite recent progress in understanding the various factors that play a role in the onset of OA, its etiology is still largely unknown. One known OA risk factor is a joint injury. 4, 5 Therefore, numerous animal models with surgically induced joint instability are utilized in the field, each with advantages and disadvantages. [6] [7] [8] [9] We chose an anterior cruciate ligament transection (ACLT) model without meniscectomy because the progression of OA is slower compared to similar models with meniscectomy. 7 We believe that this approach is likely to be more relevant to the human disease. ACLT and similar rodent models of secondary OA have been used successfully for identifying signaling networks implicated in cartilage degeneration and for characterization of gene expression. 8, [10] [11] [12] [13] [14] [15] Importantly, using this model we were able to corroborate our previous findings that utilized human OA cartilage. 13 One of the pathways implicated in OA pathology is mechanistic target of rapamycin complex 1 (mTORC1) signaling. mTOR is a Serine/Threonine kinase that coordinates cell growth and metabolism with environmental inputs, such as nutrients and growth factors. 16 mTOR kinase is present in two complexes: Rapamycin sensitive mTORC1 (mTOR complex 1) and mTORC2. mTORC1 complexes are comprised of mTOR kinase, Raptor, and GbL. 16 Aberrant mTOR activity observed in OA rodent and human cartilage was reported to affect two fundamental cellular processes: Protein synthesis 13 and autophagy. 14, [17] [18] [19] Both processes are controlled by mTORC1. Importantly, as shown in experimental rodent models, both pharmacological and genetic interventions of mTOR activity attenuates the severity of OA. 18 The precise molecular events responsible for mTORC1 dysregulation in OA cartilage remain to be elucidated. However, increased phosphoinositide 3-kinase (PI3K)/AKT activity, reported in human and rat OA cartilage, 13 is thought to mediate mTORC1 activation. We demonstrated that the translation apparatus of OA cartilage is dysregulated and hypothesized that this dysregulation would be beneficial for expression of many OA-related genes, such as proteases and cytokines. We presented the evidence that mTORC1 mediated inactivation of 4E-BP1 (eukaryotic initiation factor 4E [eIF4E] binding protein 1) is important for changes in the translational apparatus.
13 4E-BP1, an inhibitor of cap-dependent translation, is an important protein synthesis regulator 20 because protein synthesis is mostly controlled at the initiation step. During translation initiation the small ribosomal subunit, bound to several translation initiation factors and initiator Met tRNA, is recruited to mRNA. 21 This process is mediated by eIF4F, consisting of eIF4A (an RNA helicase), eIF4G (a scaffolding subunit), and eIF4E (a cap-binding protein). eIF4E binds to the 5 0 cap structure of mRNAs and therefore promotes protein synthesis. Active (hypophosphorylated) 4E-BP1 binds to eIF4E and sequesters it from active eIF4F complexes. 4E-BP1 activity is restricted by mTORC1-mediated phosphorylation, as the hyperphosphorylated form is unable to bind eIF4E. 22 Grant sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases; Grant number: R01 AR063128. Observed dysregulation of translation machinery in OA cartilage raised an important question as to when this dysregulation occurs in relation to disease progression. We therefore designed the present study as a time-course experiment in order to evaluate changes in total protein synthesis in general, with a focus on 4E-BP1 activity in particular, and to compare these changes to the histologic progression of OA. We observed changes in articular cartilage starting at 6 weeks post-surgery, with prominent signs of degeneration at 12 weeks. Similar kinetics were observed when matrix metalloproteinase 13 (MMP13) expression and activity were assayed. mTOR-mediated phosphorylation of p70S6 kinase (involved in cell proliferation) and ULK1 (a crucial player in autophagy) was detected at 8 weeks post-surgery. 4E-BP1 phosphorylation was observed starting 4 weeks postsurgery. Thus 4E-BP1 is the earliest detected mTORC1 target among those assayed. Therefore, aberrant mTORC1 activation is likely allocated disproportionately between its downstream targets during OA progression. Our work provides new insights into the sequence of molecular events leading to cartilage destruction in OA and suggests new possible players involved in cartilage breakdown following injury.
METHODS
Experimental OA in Rats and Cell Culture All experimental procedures occurred in the morning (10:00 am-12:00 pm) in a veterinary research facility. All procedures were approved by the Institutional Animal Care and Use Committee. Experimental osteoarthritis was induced in 12-week-old male Sprague Dawley rats (average weight around 300 g) as previously described. 13 Each rat was anesthetized with Isoflurane (5%), and, after being shaved and disinfected, the right knee joint was exposed through a medial parapatellar approach. The patella was dislocated laterally and the knee placed in full flexion followed by Anterior Cruciate Ligament (ACL) transection with microscissors. Then the joint surface was washed with sterile saline solution, and both capsule and skin were sutured using Vicryl 4-0 absorbable suture (Ethicon, Somerville, NJ). In sham-operated animals, wounds were closed after subluxation of the patella and saline washing. Animals were housed in pairs and chosen randomly either for ACLT or sham operation. Animals were allowed to move freely in plastic cages and had access to food and water ad libitum until they were sacrificed at 4, 6, 8, 12 , and 20 weeks after surgery for histological analysis (n ¼ 4, per group per time point), RNA isolation (n ¼ 4, per group per time point), and primary cultures (n ¼ 6, per group per time point). Buprenex (0.025 mg/kg) was used as an analgesic right before the procedure and once per day for 3 days post-surgery. All animal experiments were performed according to IACUC regulations. Cells were expanded to 70% confluency for metabolic 35 S labeling. The same cultures were used to collect supernatant for MMP13 activity (Fluorokine E kit [R&D, Minneapolis, MN]). 13 Modified Mankin Score Mankin score normally takes to account five characteristics: Structure, proteoglycan content (estimated by staining with toluidine blue-O), chondrocyte clustering/cellularity, tidemark integrity, and osteophyte presence. Since our model is mild and we observed osteophyte formation later (around 24 weeks post-surgery), this category did not have any input into the total score at the analyzed time points. The medial and lateral tibia plateau were separated in three zones. Three sections (100 mm apart) from each sample were scored by two blinded independent observers according to criteria reported previously. 3 Low scores represent minor degenerative lesions, whereas high total scores are indicative of more pronounced cartilage changes (maximum score is 18).
Immunohistochemistry (IHC) and Immunofluorescence IHC analysis for rat knee joints from ACLT-operated (n ¼ 4) and sham-operated animals (n ¼ 5) was performed as previously described. 13 To calculate percentage of positive cells the medial tibia plateau was separated in three zones, number of cells per zone was determined by H&E staining of nuclei and number of positive cells in each zone was counted and averaged per slide (n ¼ 4 slides per time point). The fold difference then was calculated to the corresponding sham operated leg. Immunofluorescence staining was performed in paraffin embedded sections (4 mm) of rat articular cartilage. Specifically, knee joints from ACLT and sham-operated rats (n ¼ 4 per time point) were harvested and fixed in 4% paraformaldehyde for 24 h and then decalcified in Formical2000 (Decal Chemical, Tallman, NY) for 96 h, followed by paraffin embedding. Sections were deparaffinized in CitriSolv (ThermoFisher Scientific, Waltham, MA) followed by gradual ethanol rehydration. Antigen retrieval was performed by incubation with proteinase-K (Sigma, Allentown, PA) for 30 min at 37˚C, followed by incubation with 0.2% Triton X-100 (Sigma) in PBS for 15 min and blocking in 2% bovine serum albumin (Sigma), 0.2% Triton-X100 for 30 min at RT. Sections were then stained overnight at 4˚C followed by secondary antibodies Alexa488-or Alexa555-conjugated goat anti-mouse, goat anti-rabbit or donkey anti-goat IgG (Molecular Probes, Eugene, OR). Slides were mounted in Fluorescent Mounting Medium (Dako, Santa Clara, CA) and stored at 4˚C in the dark. Reverse Transcription-Quantitative Polymerase Chain Reaction (qPCR) Analyses Immediately after euthanasia knee cartilage was collected and digested for 90 min with Pronase (1% w/v, Roche, Pleasanton, CA) followed by 3 h digestion with Collagenase B (0.4% w/v, Roche) to release the chondrocytes from the extracellular matrix. Total RNA was extracted using an RNeasy Mini Kit (Life Technologies, Carlsbad, CA) following the manufacturer's protocol. A 500 ng of total RNA was used for complementary DNA (cDNA) synthesis with an iScript cDNA synthesis kit (Bio-Rad, Hercules, CA). Quantitative PCR was run in a MyiQ Single-Color Real-Time PCR Detection System (Bio-Rad) using iQ SYBR Green Supermix. Relative gene expression levels were calculated using the DDCt method. Target mRNA levels were normalized to 18S ribosomal RNA. Primers used are given in Sup. 
RESULTS

Temporal Histological Assessment of Cartilage Degradation and the Corresponding Expression of Extracellular Matrix (ECM) Degrading Enzymes
To characterize the progression of cartilage degeneration following joint destabilization by ACLT, animals were sacrificed at different time points after surgery. All rats resumed weight bearing immediately after surgery upon recovery from anesthesia. A modified Mankin score was used to quantify histological changes in the medial and lateral compartments (Fig. 1A) . 6 Sham-operated joints (white bars) demonstrated minimal to no pathological changes over the 20-week time course. As shown in Figure 1A , operated joints had progressively increasing modified Mankin scores, reflecting histologic changes characteristic of OA pathology (irregular surface, decrease in superficial zone, hypercellularity, and loss of proteoglycans). Gradual damage to the cartilage, including fibrillation of the superficial zone, was most extensive at 20 weeks when scores were 10 or higher (n ¼ 4).
Increased levels of extracellular matrix (ECM) degrading enzymes, such as MMP13, MMP3, and ADAMTS5, correlate with OA severity in humans and rodents. 8 Therefore, we analyzed their expression in chondrocytes from operated and sham joints. Significant increases in the mRNA levels of Mmp13, Mmp3, and Adamts5 were observed at 12 and 20 weeks post-ACLT (Fig. 1B and C) . We further assessed the changes in Mmp13 protein abundance and active Mmp13 levels in the joints. Mmp13 protein levels, as examined by IHC, were increased markedly in the operated joint. In comparison to sham-operated cartilage, there was an increase in extracellular deposition at 12 and 20 weeks post-op (Fig. 1D) . Mmp13 enzymatic activity was measured in vitro in chondrocytes isolated from operated and sham knees. A slight increase in active Mmp13 was present already at week 4 post-surgery with further gradual upregulation starting at 8 weeks (Fig. 1E ). Mmp3 protein level was also examined in tissue sections from sham-operated and ACLT knees and a similar increase in Mmp3 protein abundance was observed (Fig. 1F) . Off note, we also observed downregulation of Sox9 protein expression in accordance with the previously described dedifferentiation of the articular chondrocytes phenotype 11 (Sup. Fig. S1B ).
Temporal Changes in Total Protein Synthesis Rates
We demonstrated previously that human and rodent OA cartilage possess accelerated rates of total protein synthesis. 13 However, whether this acceleration occurs early or late in the disease progression was not known. Thus, the rate of total protein synthesis in cells isolated from the medial tibia plateau of sham or operated knees at different time points after ACLT was determined (n ¼ 6). Total protein synthesis was measured after pulse-labeling cultured cells with a 35 S methionine/cysteine labeling mix. As shown in Figure 2A , the greatest surge in the rate of total protein synthesis (twofold) was observed in chondrocytes isolated from operated joints at 12 weeks postsurgery, followed by modest upregulation at 20 weeks post-ACLT.
Selective mTOR Activation During the Progression of OA Following ACLT Previously we implicated observed inactivation (hyperphosphorylation) of 4E-BP1 in the accelerated protein synthesis rates observed in OA cartilage. 13 This hypothesis was examined by IHC using antibodies specific for Ser65, the residue phosphorylated by mTORC1. Ser65 phosphorylation inhibits 4E-BP1 functions, directly correlating with the upregulation of protein synthesis.
21 Surprisingly, increased phosphorylation was detected at the earliest time point examined (Fig. 2B) . We next investigated by IHC the temporal phosphorylation status of other known mTORC1 targets: p70S6K and ULK1. 16 As shown in Figure 2C and D, both p70S6K and ULK1 were phosphorylated robustly at 8 weeks post-surgery. The phosphorylation levels of p70S6K were elevated at least twofold at later time points. This result implied that mTORC1 activity might be selectively regulated toward its targets; we therefore assayed the phosphorylation status of 4E-BP1 and p70S6K by immunofluorescence (IF) to directly compare the levels of phosphorylated proteins in the joints. As shown in Figure 3A , there were very few positive cells for phospho-p70S6K at 4 weeks post-ACLT, while about 20% of cells stained positive for phospho-4E-BP1. Accordantly, merged images were mostly red. The percentage of cells positive for both targets was similar at 12 weeks post-op which is apparent from the merged image as well. Cells expressing Mmp13 were stained positively for 4E-BP1(S65) indicating its contribution to the disbalanced of chondrocytes homeostasis. We also analyzed phosphorylation status of 4E-BP1 and p70S6K by western blot. Lysates prepared directly from the chondrocytes isolated from ACLT or sham joints were separated on polyacrylamide gels. As shown in Figure 3C , while total levels of proteins are similar at 4, 6, 8, and 12 weeks post-op (and Ref. 13 ),
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KATSARA AND KOLUPAEVA 4E-BP1 phosphorylation was detected 4 weeks earlier than p70S6K phosphorylation. Clearly, 4E-BP1 is phosphorylated preferentially at earlier time points following ACLT. This may be a cell-type specific effect, we therefore examined mTORC1 activity toward 4E-BP1 and p70S6K in rat articular chondrocytes (RAC). IL-1b treatment of RAC induces robust phosphorylation of both targets (Fig. 3D,   13 ). We used a panel of rapamycin doses to inhibit mTORC1 activity. 23 Rapamycin exhibited differential regulation of p70S6K and 4E-BP1 (Fig. 3D) . Even the lowest concentration potently inhibited p70S6K phosphorylation, while 4EBP1 phosphorylation was fully inhibited only by the highest Rapamycin concentration. This result suggests a differential regulation of the two known mTORC1 substrates.
Increased 4EBP1 phosphorylation ultimately results in upregulation of protein synthesis. This might be reflected in the increased rate of total protein synthesis or in increased translation of select mRNAs. Interestingly, we observed that 4E-BP1 protein levels were decreased at 12 and 20 weeks post-surgery (Fig. 4B) . Accordingly, we observed significant downregulation of 4E-BP1 mRNA at 12 and 20 weeks postop (Fig. 4A) . This unexpected change in 4E-BP1 abundance in ACLT joints would indirectly decrease 4E-BP1 activity as well, similar to the reported increase in the protein phosphorylation. Our data indicate that 4E-BP1 activity in ACLT joints is likely regulated at multiple (transcriptional and post-translational) levels within the cells, affecting overall protein synthesis in diseased cartilage.
DISCUSSION
Many factors play a role in the onset and progression of OA; therefore it is clear that no animal model can fully reflect the human disease. However, as joint injuries are well-known risk factors for developing OA, animal models of posttraumatic (secondary) OA are used extensively. 9 These models provide a unique opportunity to investigate the mechanisms involved in the onset of OA and to understand major steps In the current study, we used a rat ACLT model because the size of the animal allowed for easier standardization of surgical procedures and provided sufficient material for isolating cells. This model exhibits many features of the human disease; notably cartilage degeneration and aberrant activity of many signaling molecules such as mTOR. 8, 13, 14 We chose to perform only ACLT in our model to minimize possible variations in the induced joint instability and to have slow disease progression. As expected, we observed a delay in pathological changes when compared to more aggressive OA models. 7 We also observed slightly slower cartilage degeneration compared to a similar model reported by Hayami et al. 7 likely due to variations in surgical techniques, animal facilities and etc. In line with previous reports, the first changes, such as swelling of chondrocytes and fibrillation, occurred in the superficial zone. We detected upregulation of Mmp13 protein levels (and activity) at 4 weeks, but levels of mRNA expression were increased later (at 12 weeks). This is likely due to the mild phenotype of a solely ACLT model, as Appleton et al. using a rat ACLT model in combination with partial medial meniscectomy and forced immobilization 8 observed an increase in Mmp13 expression at 4 weeks following surgery. Detected at 4 weeks, upregulation of Mmp13 protein abundance with a modest temporary increase in the active Mmp13 might be similar to the transient increase in Mmp13 expression starting 1 week after surgery and vanishing by week 4 as reported in the more aggressive ACLT/partial medial meniscectomy model. 24 Clearly, though cartilage degeneration within the ACLT model takes longer than in more aggressive models, it is still suitable for preclinical studies of OA.
In this work we used only male rats. Current data on ACLT in female rats is limited; in females, ACLT is mostly used in combination with ovariectomy, which was not relevant to our study. 25 Additional similar studies should be carried out in female rats to validate the relevance of our data.
Aberrant mTOR activity in OA cartilage was reported by us and others. [12] [13] [14] 26 However, its temporal changes following surgically induced joint instability has not been examined. Here, for the first time, we report that mTORC1 preferentially phosphorylates 4E-BP1, rather than p70S6K and ULK1, at early time points following surgery. We analyzed mTORC1 activity by monitoring the phosphorylation status of its three known targets: 4E-BP1, p70S6K, and ULK1. The first two are crucial players in the regulation of protein synthesis and the latter is essential for autophagy. 27 We observed an increase in ULK1 phosphorylation on Ser757 (which inhibits autophagy) at week 8 post-surgery. This is consistent with previously published data 14, 17, 19 and would result in diminished autophagy in OA cartilage. Similar timing was detected for p70S6K phosphorylation. However, 4E-BP1 phosphorylation was noticeable 4 weeks earlier.
The discrepancy in the timing of p70S6K and 4E-BP1 phosphorylation was reported before and was attributed to differential binding affinities of the two substrates; p70S6K binds much weaker to mTORC1 than 4E-BP1. 28 A similar situation is plausible in the case of ULK1 and p70S6K in articular cartilage. In addition to this kinetically regulated mechanism, the binding of substrates, and kinase activity itself, can be 
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KATSARA AND KOLUPAEVA affected by other proteins whose expression/activity changes during the progression of OA. For example, a decrease in the expression of the mTORC1 negative regulator, REDD1, could account for the increased kinase activity. 17 Further experiments are needed to evaluate 4E-BP1 phosphorylation relative to the phosphorylation of other mTOR targets, such as Lipin, CLIP170, and PKCa.
Surprisingly, while the levels of hypophosphorylated 4E-BP1 remained high at early times, upregulation of total protein synthesis was observed later when cartilage degeneration became apparent. This implies that this inactivation is likely utilized by a specific pool of mRNAs rather than by a majority of mRNAs. It is well-accepted that different mRNAs have different requirements for eIF4E activity, depending on the length and structure of their 5 0 -untranslated region. It is important to understand what specific mRNAs might benefit from an early increase in eIF4F activity.
Among targets whose expression increases shortly following the introduction of surgical instability in mice is the C-X-C motif chemokine receptor 4, whose GC rich 5 0 -UTR makes it a plausible candidate. 11 4E-BP1 inactivation might also be a part of an immediate response that is adaptive to changes in the loading response. Specifically, it was suggested that gene expression in the destabilized joint is rapid and highly mechanosensitive, 29 and so is the translation apparatus. 30 A decrease in 4E-BP1 expression at later times during the progression of OA would also increase the proportion of active eIF4F in OA cartilage. Interestingly, the increase in rate of total protein synthesis peaks at 12 weeks and is more modest at 20 weeks post-surgery. This might implicate that while 4E-BP1 is still inactivated (either by phosphorylation or by mRNA downregulation) the translation machinery has finished the "adaptation process" and is at a more steady state. Therefore the difference in the rate of In summary, our data provides a temporal characterization of molecular changes in the rat ACLT model of OA and, for the first time, indicates that 4E-BP1 inactivation precedes cartilage degeneration and increased expression of pathogenic proteases in cartilage. Further studies will be needed to determine the importance of these findings for human OA. Importantly, observations made in this study suggest that translation control is crucial at the onset of OA as it enables rapid accommodation to the induced joint instability and likely facilitates the significant alterations observed in gene expression at early time points.
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